NeuroBo Pharmaceuticals looking to Retrace

(24/7 MARKET NEWS) – NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) is trying to regain territory that it lost last week, after it announced, on the 4th, a $30 million underwritten public offering.

The stock is attempting to bounce off the new 52-week low of $2.16, which it set yesterday, as it’s trading at $$2.93, up $0.77 (+35.65%).

It should have minimum resistance to the $4.30 level. If it can break through that resistance, on strong volume, it should not have much resistance until it approaches the $7 level.

24/7 MARKET NEWS, INC Disclaimer

24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to or for further information.


Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist